Forget the scars of the past, this is day zero, insists Cann Group boss by Steve Jones June 22, 2023April 30, 2024 In the first of a two-part interview, Cann Group CEO Peter Koetsier tells Cannabiz how the […]
Cann Group in multimillion-dollar cap raise to fund Mildura production growth by Steve Jones June 15, 2023April 30, 2024
Company news: Medicinal Harvest; Cannasouth/Eqalis; Cann Group; MGC Pharma; Incannex; Neurotech by Martin Lane May 3, 2023April 30, 2024
Revenues and costs on the rise as Cann Group increases Mildura production by Steve Jones April 28, 2023April 30, 2024
Cann Group prepares for ‘quantum step’ but remains shy on positive cash flow timeframe by Steve Jones April 18, 2023April 30, 2024
Industry braces for change in pursuit of long-term success by Steve Jones March 20, 2023April 30, 2024
Cann Group to focus on ‘production at scale’ as new CEO beds down by Steve Jones February 28, 2023April 30, 2024
Cann Group revenue climbs 83% but losses deepen to A$18.8 million by Steve Jones February 24, 2023April 30, 2024
‘We’re not giving up,’ says new Cann Group CEO as researchers pore over clinical trial results by Steve Jones January 24, 2023March 13, 2023
